article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

FDA Law Blog

This individual will play a key role in overseeing the new integrated Hub model and helping to develop and implement its strategic agenda action plan. According to FDA, the new Hub will have special focus on products intended for smaller populations and also for diseases where the natural history is variable and not fully understood.

article thumbnail

Wrapping up 2022! (Residency Life, Mom Life, and Blog Milestones)

Aspiring Minority Doctor

I'm just seriously so blessed to have such an amazing daughter and I'm even more so grateful that I was able to spend her special day with her and celebrate in a way that she wanted. I continue to be grateful for each and every individual who takes the time out of their busy lives to read my blog. Thankful for you!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical Trials Join the Remote Work Revolution: FDA’s New Draft Guidance on Decentralized Clinical Trials

FDA Law Blog

FDA has also launched a series of five public workshops on issues related to DHTs in regulatory decision-making. Dr. Sacks also explained that DHTs and DCTs may “open access to research” for older individuals and people with disabilities who are not able to travel to clinical trial sites, but could participate from home or a nearby clinic.

Clinic 59
article thumbnail

Writing for the Lay Public: Rosanne Leipzig and Louise Aronson

GeriPal

We have two authors, books, op-eds, prolific authors, and today’s podcast is a two-part special. And then I feel like when I’m in clinic I’m helping individuals, and you only have so much time to help so many people. I give hour long talks on this and do three hour long workshops. Great line. Rosanne: It is.

IT 106